Comments
Dr Reddy’s Laboratories stock found support at ₹5,600 three weeks ago. It bounced off this level and has been gaining since then. After surpassing the resistance at ₹6,000 last week, the stock went to consolidation phase. That is, it has been oscillating between ₹6,000 and ₹6,130. But on Tuesday, it broke out of this range, opening the door for further upside. Nevertheless, there is a chance for the stock to see a minor corrective decline in price before witnessing the next leg of rally. So, traders can buy now at ₹6,165 and on a dip to ₹6,100. Place stop-loss at ₹5,980 at first.
Raise this to ₹6,050 when the share price hits ₹6,250. Tighten the stop-loss further to ₹6,280 when the stock touches ₹6,350. Exit at ₹6,400.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.